Amylyx Pharmaceuticals, Inc. (AMLX)
38.14
-0.52
(-1.35%)
USD |
NASDAQ |
Aug 24, 16:00
38.14
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Price to Book Value : 17.76 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 18.00 |
| August 20, 2026 | 18.47 |
| August 19, 2026 | 17.97 |
| August 18, 2026 | 16.35 |
| August 17, 2026 | 9.979 |
| August 14, 2026 | 10.07 |
| August 13, 2026 | 10.47 |
| August 12, 2026 | 10.87 |
| August 11, 2026 | 11.00 |
| August 10, 2026 | 10.56 |
| August 07, 2026 | 10.63 |
| August 06, 2026 | 11.26 |
| August 05, 2026 | 10.17 |
| August 04, 2026 | 10.18 |
| August 03, 2026 | 9.392 |
| July 31, 2026 | 9.457 |
| July 30, 2026 | 9.662 |
| July 29, 2026 | 9.187 |
| July 28, 2026 | 9.104 |
| July 27, 2026 | 9.076 |
| July 24, 2026 | 8.573 |
| July 23, 2026 | 8.191 |
| July 22, 2026 | 8.242 |
| July 21, 2026 | 8.615 |
| July 20, 2026 | 8.126 |
| Date | Value |
|---|---|
| July 17, 2026 | 8.265 |
| July 16, 2026 | 7.925 |
| July 15, 2026 | 8.279 |
| July 14, 2026 | 8.475 |
| July 13, 2026 | 8.107 |
| July 10, 2026 | 8.275 |
| July 09, 2026 | 8.559 |
| July 08, 2026 | 8.326 |
| July 07, 2026 | 8.461 |
| July 06, 2026 | 8.368 |
| July 02, 2026 | 8.508 |
| July 01, 2026 | 8.358 |
| June 30, 2026 | 8.363 |
| June 29, 2026 | 7.601 |
| June 26, 2026 | 7.231 |
| June 25, 2026 | 7.088 |
| June 24, 2026 | 6.910 |
| June 23, 2026 | 6.654 |
| June 22, 2026 | 6.617 |
| June 18, 2026 | 6.369 |
| June 17, 2026 | 6.198 |
| June 16, 2026 | 6.117 |
| June 15, 2026 | 6.174 |
| June 12, 2026 | 5.930 |
| June 11, 2026 | 5.654 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pfizer Inc. | 1.872 |
| Eli Lilly & Co. | 34.67 |
| Merck & Co., Inc. | 8.873 |
| EyePoint, Inc. | 2.490 |
| Bristol Myers Squibb Co. | 6.161 |
Price to Book Value Related Metrics
| Price | 38.14 |
| Earnings Yield | -3.76% |
| Market Cap | 4.248B |